CA.med: MCCQE & NAC OSCE

CA.med is a focused exam-prep app for international medical graduates heading for Canada, built around the MCCQE Part I and the NAC OSCE.

Everything is organised as one guided route rather than a pile of resources, so you always know what to study next and how far along you are.

THE PATHWAY
NAC OSCE → MCCQE Part I → provincial licensing

Provincial licensing routes and language requirements are mapped into the same pathway.

WHAT YOU GET

• Question bank: exam-style questions with worked explanations, so a wrong answer teaches you something instead of just scoring you.
• Flashcards: spaced repetition on the high-yield facts that these exams keep coming back to.
• Clinical simulations: work through realistic patient encounters step by step: history, examination, documentation and reasoning.
• Progress tracking: see which topics are solid and which need another pass, by subject and over time.
• Offline-friendly: study on a commute or a night shift without a connection.

BUILT FOR HOW DOCTORS ACTUALLY STUDY
Short sessions that fit between shifts. A dashboard that opens on what you were last doing. No streak pressure, no noise, just the next useful thing.

WHO IT IS FOR
Medical students, junior doctors and international medical graduates preparing for the MCCQE Part I and the NAC OSCE. Useful whether you are starting the process or revising in the final weeks.

SUBSCRIPTION
CA.med Pro is available as a monthly or annual auto-renewing subscription. Payment is charged to your Apple Account at confirmation of purchase. The subscription renews automatically unless it is cancelled at least 24 hours before the end of the current period, and your account is charged for renewal within 24 hours of the end of that period. You can manage or cancel your subscription in your Apple Account settings after purchase.

Terms of Use (EULA): https://medhub.one/terms
Privacy Policy: https://medhub.one/privacy

CA.med is an educational tool. It does not replace professional medical judgement, clinical training, or official guidance from the relevant regulator.